HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Company’s vice president of global finance, as its interim chief financial officer and treasurer, effective upon Mr. Rossi’s resignation. Mr. […]
Michael Chambers, the founding CEO of Aldevron, has been elected to the board of directors for the Whitehead Institute at the Massachusetts Institute of Technology. The Whitehead Institute is a nonprofit biomedical research center in Cambridge, Massachusetts. Chambers is one of two new members elected to a six-year term on the board that were announced […]
SFW Capital-Backed Pion’s Acquisition of Two Square Science Adds Sample Preparation and Remote Monitoring Technology to Augment Its Product Portfolio Billerica, MA: Pion, Inc. (“Pion”), a leading provider of innovative analytical solutions for drug development, has acquired Two Square Science, a company specializing in sample preparation, content uniformity and remote monitoring solutions for the life […]
The Protein Sequencing Company™ Commercializing the Industry’s First System to Enable Next-Generation, Single-Molecule Protein Sequencing Will Serve on HUPO’s Industrial Advisory Board GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has joined the Human Proteome Organization (HUPO) Industrial Advisory Board (IAB), an international scientific organization focused on fostering […]
Antigen designed to support immunoassay and vaccine development applications Oxford, UK: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the worldís leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein (SEBOV GP). The addition […]
BOULDER, Colo. — SomaLogic, Inc., a leader in proteomics technology, announced today the full-scale global launch of the SomaLogic™ Certified Site program, which will allow institutions around the world to run the 7,000-plex SomaScan® Assay in their own labs. By becoming a SomaLogic Certified Site, labs can run assays on SomaLogic’s SomaScan® Platform—the largest commercially available proteomics […]
Products Represent the Highest Plex In Situ Imager and the First Cloud-Based Data Analysis Suite for Spatial Biology SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first commercial shipment of the CosMx™ Spatial Molecular Imager (SMI) and the AtoMx™ Spatial Informatics […]
Addition Further Strengthens Bruker’s Solutions for Neuroscience Research BILLERICA, Massachusetts – Bruker Corporation today announced that it has completed its acquisition of Neurescence Inc., an innovative provider of ultralight fiber-bundle MultiscopesTM for simultaneous multi-region, optical functional neuroimaging. Bruker anticipates the acquisition will bolster its position as the leading provider of freely behaving animal imaging and […]
Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023 Carl Hull to continue to serve as Executive Chairman and Interim CEO SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a […]
Single analyte biomarker kit reagents introduced for the quantification of five human inflammatory cytokines First kits available in expanding offering to support biomarker studies Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
